| Literature DB >> 32726628 |
Anna Shcherbina1, Jacqueline Larouche2, Paula Fraczek2, Benjamin A Yang2, Lemuel A Brown3, James F Markworth3, Carolina H Chung4, Mehwish Khaliq5, Kanishka de Silva2, Jeongmoon J Choi6, Mohammad Fallahi-Sichani7, Sriram Chandrasekaran4, Young C Jang6, Susan V Brooks8, Carlos A Aguilar9.
Abstract
During aging, there is a progressive loss of volume and function in skeletal muscle that impacts mobility and quality of life. The repair of skeletal muscle is regulated by tissue-resident stem cells called satellite cells (or muscle stem cells [MuSCs]), but in aging, MuSCs decrease in numbers and regenerative capacity. The transcriptional networks and epigenetic changes that confer diminished regenerative function in MuSCs as a result of natural aging are only partially understood. Herein, we use an integrative genomics approach to profile MuSCs from young and aged animals before and after injury. Integration of these datasets reveals aging impacts multiple regulatory changes through significant differences in gene expression, metabolic flux, chromatin accessibility, and patterns of transcription factor (TF) binding activities. Collectively, these datasets facilitate a deeper understanding of the regulation tissue-resident stem cells use during aging and healing.Entities:
Keywords: 1-carbon metabolism; Ddit3; MyoD; expression; heterochromatin; regeneration; transcription factor binding; vitamin A
Year: 2020 PMID: 32726628 PMCID: PMC8025697 DOI: 10.1016/j.celrep.2020.107964
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423
Figure 1.Muscle Stem Cells Act Aberrantly as a Result of Aging and Poorly Regenerate Muscle after Injury
(A) Schematic of experiment whereby young (2–3 months) and aged (22–24 months) mice are injured by BaCl2 injection in hindlimb muscles (gastrocnemius and tibialis anterior [TA]) and muscle stem cells (MuSCs) are isolated with FACS, pooled across muscles, and profiled during muscle regeneration by using genome-wide chromatin accessibility and gene expression measurements.
(B) Histological assessment (top) and quantification of mean regenerating fiber cross-sectional area (CSA) size (identified through centrally located nuclei) from TA muscles harvested from young and aged mice 7 days post-injury with hematoxylin and eosin (H&E) staining. *p < 0.05, calculated by two-sided, two-sample Student’s t test assuming equal population variance from n = 4 biological replicates.
(C) Representative FACS plots showing negative (Sca-1, Mac-1, CD45, and Ter-119) and positive (CXCR4 and b1-Integrin) surface markers where numbers within gates indicate percentage of cells within gate.
(D) Heatmap of differential expression for 4,985 genes plotted as Z score for young and aged MuSCs isolated from different days post-injury. Clusters are identified by color on the left side of the heatmap.
(E) Dirichlet Process Gaussian Process (DPGP) mixture model-based clustering of gene expression time series data defined as the Z score of young over aged (gray represents 2× standard deviation and black line is cluster mean), where cluster peaks are corresponding to day of MuSC isolation and color-coded to match clusters in (D).
(F) Enriched GO and KEGG pathways for a subset of clusters from (E) that are color-coded.
(G) Venn diagrams of differentially expressed genes from freshly isolated, uninjured, or activated MuSCs from young and aged mice and human MuSCs24. Activated MuSCs were isolated from 3 dpi from young and aged murine muscle and 7 days in culture for human MuSCs, when both of which have undergone at least one cellular division.
(H) Enriched pathways from unique and shared genes from (G). FI, pathways from common genes among all freshly isolated MuSCs; FI–M, pathways from common genes among mouse freshly isolated MuSCs; FI–A, pathways from genes among aged mouse freshly isolated MuSCs; FI–Y, pathways from genes among young mouse freshly isolated MuSCs; Ac, pathways from common genes among all activated MuSCs; Ac–M, pathways from common genes among mouse activated MuSCs; Ac–A, pathways from common genes among aged mouse activated MuSCs; Ac–Y, pathways from common genes among young mouse activated MuSCs.
Figure 2.Alterations in Metabolism Associate with Global Changes in Histone Methylation of Young and Aged MuSCs
(A) Histogram (top) and jitter plot (bottom) showing significant changes in reaction flux plotted as the Z score for each metabolic reaction between young and aged MuSCs using a paired t test (p < 0.05).
(B) Representative immunofluorescence (IF) staining of total histone levels (H3) and repressive chromatin modifications (H3K27me3 and H3K9me3) for young and aged MuSCs. Scale bar represents 100 µm.
(C) Quantification of stains from (B) show higher histone levels (H3) and constitutive heterochromatin modifications (H3K9me3) for young MuSCs, where aged MuSCs displayed an increase in facultative heterochromatin modifications (H3K27me3). ****p < 0.001, as calculated by two-sided, two-sample Student’s t test. n = 1,765–3,825 cells from each of two young and two aged mice.
(D) Heatmap of gene expression for methyltransferases and chromatin enzymes in young and aged uninjured MuSCs plotted as Z score.
Figure 3.Retinoic Acid Receptors Contribute to Maintenance of MuSC Quiescence but Are Lost in Age
(A) Heatmap of gene expression for genes encoding retinoic acid receptors and retinoid x receptors as well as several downstream retinoic acid target genes in young and aged uninjured MuSCs, plotted as Z scores of transcrips per million (TPM) values.
(B) Representative IF staining of Pax7 and MyoD for young and aged MuSCs following 3 days of treatment of retinoic acid (+RA) or DMSO alone (−RA). Scale bars represents 50 µm in images of aged MuSCs and 25 µm in images of young MuSCs.
(C) Quantitation of images in (B) using a two-sample Student’s t test shows that treatment with ATRA increased Pax7 in young MuSCs (**p < 0.01), decreased MyoD in both young MuSCs and aged MuSCs (****p < 0.0001 and *p < 0.05, respectively), and decreased Ki67 in both young MuSCs and aged MuSCs (*p < 0.05 and **p < 0.01, respectively). Cells were harvested from muscles of two young and two aged mice. In total, at least 50 cells were stained and analyzed per condition. A two-sided, two-sample t test was used to calculate statistical significance.
Figure 4.Chromatin Accessibility Is Modified during MuSC Regeneration and Exhibits Divergent Regenerative Trajectories in Aging
(A) Heatmap of Spearman correlation coefficients for individual replicates isolated from age and time points showing strong reproducibility. Correlation was computed on asinh (counts per million) reads after removal of the contributions from surrogate variables.
(B) Multi-dimensional scaling (MDS) of ATAC-seq enrichments color-coded by day of isolation; circles represent aged samples, and triangles represent young samples.
(C) Intersection of differentially accessible (young versus aged) ATAC-seq peaks from day 0 with H3K27me3 sites previously derived for young and aged MuSCs.
(D) Statistically enriched (Benjamini-Hochberg corrected, p < 0.01) pathways from different days derived from ATAC-seq enrichments using GREAT analysis.
Figure 5.Aging Engenders Variations in Transcription Factor Binding Dynamics during Regeneration
(A) Comparison of fold change in transcription factor expression in young and aged (x axis) with the HOMER fold enrichment of the corresponding transcription factor binding motif in young and aged over background (y axis). Motifs enriched at day 0 in either young (y axis > 0) or aged (y axis < 0). Points on the chart are sized proportionally to median TPM for the corresponding day and color-coded by the motif family to which they belong.
(B) Normalized tracks of ATAC-seq datasets (fold change of ATAC-seq signal relative to the mm10 background distribution) around the MyoG locus (left) and Mef2a (right), where differences in enrichments are highlighted in gray and all tracks are scaled to the same level (fold change, 0–20).
(C) Top: comparison of aggregate MyoD footprints in young versus aged for each day of isolation, where the y axis values are are logarithms of reads per motif site and the x axis is the distance away from the center of the footprint (+/− 0.1 kb from motif center).
(D) Schematic of approach to distinguish direct and indirect binding of MyoD transcription factor whereby MyoD ChIP-seq peaks are categorized for ATAC-seq footprints (FP) and position weight matrix (PWM).
(E) Annotated distribution of MyoD ChIP-seq peaks (y axis) in young (Y) and aged (A) MuSCs for each time point of isolation before and after injury.
(F) Gene expression heatmap plotted as Z score for each time point of isolation before and after injury for MyoD co-binding partners identified through indirectly bound MyoD sites and PWM of a second factor.
Figure 6.Silencing Ddit3 Restores Myogenic Differentiation in Aged MuSCs
(A) Representative IF staining of aged MuSCs differentiated into myoblasts or myotubes for 3 days after knockdown (KD) of Ddit3, where myosin heavy chain 3 (green) and DAPI (blue) are shown. Scale bar represents 100 µm)
(B) Enumeration of fusion index for differentiated myoblasts shows KD of Ddit3 induced more fusion. n = 3 independent experiments. *p < 0.05, calculated by two-sample Student’s t test assuming equal population variance.
(C) qPCR of Myogenin (MyoG) following siRNA KD of Ddit3 and 3 days post-differentiation shows upregulation of MyoG. Bars show mean ± standard deviation. n = 3 replicates; ns denotes not significant (p > 0.05), calculated by Student’s t test assuming equal population variance.
KEY RESOURCES TABLE
| REAGENT or RESOURCE | SOURCE | IDENTIFIER | ||
|---|---|---|---|---|
| Antibodies | ||||
| APC anti-mouse Ly-6A/E (Sca-1), clone: D7, isotype: Rat IgG2a, κ | BioLegend | Cat# 108112; RRID:AB_313349 | ||
| APC anti-mouse CD45, clone: 30-F11, isotype: Rat IgG2b, κ | BioLegend | Cat# 103112; RRID:AB_312977 | ||
| APC anti-mouse/human CD11b, clone: M1/70. Isotype: Rat IgG2b, κ | BioLegend | Cat# 101212; RRID:AB_312795 | ||
| APC anti-mouse TER-119, clone: TER-119, isotype: Rat IgG2b, κ | BioLegend | Cat# 116212; RRID:AB_313713 | ||
| PE anti-mouse/rat CD29, clone: HMβ1–1, isotype: Armenian Hamster IgG | BioLegend | Cat# 102208; RRID:AB_312885 | ||
| Biotin Rat Anti-Mouse CD184, clone: 2B11/CXCR4 (RUO), isotype: Rat IgG2b, κ, lot # 6336587 | BD Bioscience | Cat# 551968; RRID:AB_394307 | ||
| Streptavidin PE-Cyanine7, lot # 4290713 | eBioscience | Cat# 25–4317-82; RRID:AB_10116480 | ||
| Mouse anti-human myosin (embryonic), Isotype: Mouse IgG1, supernatant | Developmental Studies Hybridoma Bank | Cat# F1.652 s | ||
| Mouse anti-Pax7, Isotype MIgG1, kappa light chain, supernatant | Developmental Studies Hybridoma Bank | Cat# Pax7 s | ||
| Anti-Histone H3, rabbit polyclonal | Abcam | Cat# ab1791; RRID:AB_302613 | ||
| Tri-Methyl-Histone H3 (Lys27), rabbit monoclonal, clone C36B11 | Cell Signaling Technology | Cat# 9733; RRID:AB_2616029 | ||
| Tri-Methyl-Histone H3 (Lys9), rabbit monoclonal, clone D4W1U | Cell Signaling Technology | Cat# 13969 RRID:AB_2798355 | ||
| Donkey anti-rabbit IgG (H+L), Alexa Fluor 647 | Thermo Fisher | Cat# A-31573; RRID:AB_2536183 | ||
| Rabbit anti-mouse laminin 1+2, Isotype: Polyclonal IgG | Abcam | Cat# ab7463,;RRID:AB_305933 | ||
| Goat anti-mouse IgG1, Alexa Fluor 488 conjugate | Invitrogen | Cat# A-21121; RRID:AB_2535764 | ||
| Goat anti-rabbit H+L, Alexa Fluor 555 conjugate | Invitrogen | Cat# A-21428; RRID:AB_141784 | ||
| Goat anti-mouse H+L, Alexa Fluor 555 conjugate | Invitrogen | Cat# A28180; RRID:AB_2536164 | ||
| Anti-Pax7 antibody, mouse monoclonal IgG1, Alexa Fluor 488 conjugate | Santa Cruz Biotechnology | Cat# sc-81648; RRID:AB_2159836 | ||
| Anti-MyoD antibody (G2), mouse monoclonal IgG2b, Alexa Fluor 647 conjugate | Santa Cruz Biotechnology | Cat# sc-377460; RRID:AB_2813894 | ||
| Anti-MyoD antibody (G2), mouse monoclonal IgG2b, Alexa Fluor 647 conjugate | Santa Cruz Biotechnology | Cat# sc-377460; RRID:AB_2813894 | ||
| Anti-Ki-67antibody, mouse monoclonal IgG1, PE conjugate | Santa Cruz Biotechnology | Cat# sc-23900; RRID:AB_627859 | ||
| Chemicals, Peptides, and Recombinant Proteins | ||||
| Dispase II (activity ≥ 0.5 units/mg solid) | Sigma | D4693–1G | ||
| Collagenase Type II (654 U/mg, non-specific proteolytic activity 487 U/mg) | Life Technologies | 17101015 | ||
| Barium Chloride (BaCl2) solution (20% w/v) | Fisher Scientific | SB822–1 | ||
| Digitonin | Promega | G9441 | ||
| NP40 | Sigma/Roche | 11332465001 | ||
| 1M Tris-HCl pH 7.5 | Invitrogen | 15567–027 | ||
| 1M MgCl2 | Thermo Fisher | AM9530G | ||
| DMEM, high glucose, pyruvate | Life Technologies | 11995065 | ||
| Ham’s F-10 Nutrient Mix | Life Technologies | 11550043 | ||
| Fetal Bovine Serum | Life Technologies | 10437028 | ||
| HBSS, no calcium, no magnesium, no phenol red | Life Technologies | 14175145 | ||
| Propidium Iodide - 1.0 mg/mL Solution in Water | Life Technologies | P3566 | ||
| Mouse on Mouse blocking reagent | Vector Labs | MKB-2213 | ||
| Isofluorane | Vet One | 502017 | ||
| Hematoxylin | Ricca Chemical Company | 3530–16 | ||
| Eosin | EMD-Millipore | 588X-75 | ||
| DDIT3 DsiRNA 13.9 | Integrated DNA Technologies | mm.Ri.Ddit3.13.9 | ||
| DDIT3 DsiRNA 13.1 | Integrated DNA Technologies | mm.Ri.Ddit3.13.1 | ||
| Matrigel | BD Biosciences | 356234 | ||
| Horse Serum | GIBCO-Invitrogen | 26050088 | ||
| 0.25% Trypsin EDTA | GIBCO-Invitrogen | 25200072 | ||
| Opti-MEM | Thermo Fisher | 31985088 | ||
| Lipofectamine RNAiMAX | Lifetech | S-006–100 | ||
| Fibroblast Growth Factor basic | GIBCO-Invitrogen | PHG0263 | ||
| Penicillin Streptomycin | GIBCO-Invitrogen | 15640055 | ||
| QIAzol | QIAGEN | 79306 | ||
| Hoechst 33342 | Thermo Fisher | H3570 | ||
| Tween-20 | Sigma Aldrich | P1379 | ||
| Triton X-100 | Sigma Aldrich | T8787 | ||
| SYBR Green PCR MasterMix | Thermo Fisher | 4309155 | ||
| PrimeTime Mouse GAPDH Primer | Integrated DNA Technologies | Mm.PT.39a1 | ||
| PrimeTime Mouse DDIT3 Primer | Integrated DNA Technologies | Mm.PT.58.30882054 | ||
| TissuePlus O.C.T Compound | Fisher Scientific | 23–730-571 | ||
| Dako Fluorescence mounting media | Agilent | S3023 | ||
| Hoechst 33342 | Thermo Fisher | H3570 | ||
| 4’,6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI), FluoroPureTM grade | Invitrogen | D21490 | ||
| MitoTracker Deep Red | Thermo Fisher | M22426 | ||
| Corning CellTak | Fisher Scientific | C354240 | ||
| Gelatin from porcine skin, type A | Sigma Aldrich | G2500 | ||
| All-trans Retinoic Acid | Fisher Scientific | AC207341000 | ||
| Dimethyl sulfoxide, Hybri-Max sterile-filtered BioReagent | Sigma Aldrich | D2650 | ||
| Critical Commercial Assays | ||||
| Smart-Seq v4 Ultra Low Input RNA Kit | Clontech | 634888 | ||
| Nextera XT DNA Library Preparation Kit | Illumina | FC-131–1024 | ||
| NextSeq 500/550 High Output Kit v2 (150 Cycles) | Illumina | FC-404–2002 | ||
| Nextera DNA Library Preparation Kit | Illumina | FC-121–1030 | ||
| SuperScript III First-Strand Synthesis Kit | Thermo Fisher | 18080051 | ||
| QIAGEN miRNeasy Micro Kit | QIAGEN | 217084 | ||
| Satellite Cell Isolation Kit, mouse | Miltenyi | 130–104-268 | ||
| Deposited Data | ||||
| ATACseq and RNaseq Datasets | This Manuscript | |||
| Experimental Models: Organisms/Strains | ||||
| C57BL/6 wild-type female mice (3–4 months) | Charles River Labs | Strain 027 | ||
| C57BL/6 wild-type female mice (20–24 months) | NIA | Strain 027 | ||
| Pax7CreER/+;Rosa26mTmG/+ female mice (3 months) | Jackson Labs | Stock #017763 crossed with stock #007676 | ||
| Pax7CreER/+;Rosa26nTnG/+ female mice (5 months) | Jackson Labs | Stock #017763 crossed with stock #023537 | ||
| Software and Algorithms | ||||
| Bowtie2 | ||||
| Samtools | ||||
| STAR | ||||
| RSEM | ||||
| limma | ||||
| Voom | ||||
| SVA | ||||
| DPGP clustering | ||||
| DAVID | ||||
| MISO | ||||
| ENCODE ATAC-seq processing pipeline | ||||
| cutadapt | ||||
| MACS2 | ||||
| Bedtools | ||||
| GREAT | ||||
| ChromHMM | ||||
| HOMER | ||||
| DeepTools | ||||
| R v3.4.1, v.3.5.0 | The R Foundation for Statistical Computing | |||
| Other | ||||
| Bioinformatics analyses code | This manuscript | |||
| H3K4me3 ChIPseq−Satellite Cells | GEO:GSM1148118, GEO:GSM1148110 | |||
| H3K4me3 ChIPseq−Myoblasts | ENCODE | ENCODE:ENCFF360QRN | ||
| H3K27me3 ChIPseq−Satellite Cells | GEO:GSM1148119, GEO:GSM1148111 | |||
| H3K27me3 ChIPseq−Myoblasts | ENCODE | ENCODE:ENCFF569LDY | ||
| MyoD1 ChIPseq | ENCODE | ENCODE:ENCFF423NWT | ||
| MyoG ChIPseq | ENCODE | ENCODE:ENCFF980DKG | ||
| CTCF ChIPseq | ENCODE | ENCODE:ENCFF297NKN | ||
| Satellite Cells | Myoblasts | |
|---|---|---|
| H3K4me3 | ENCODE | |
| • d0 Aged (GSM1148118) | • ENCFF360QRN | |
| • d0 Young (GSM1148110) | ||
| H3K27me3 | ENCODE | |
| • d0 Aged (GSM1148119) | • ENCFF569LDY | |
| • d0 Young (GSM1148111) | ||
| MyoD1 | ENCODE | |
| • ENCFF423NWT | ||
| MyoG | ENCODE | |
| • ENCFF980DKG | ||
| CTCF | ENCODE | |
| • ENCFF297NKN |